In 2023, neoplasm mortality in the US was recorded at 176.2 deaths per hundred thousand persons. Forecasts indicate a consistent decline from 2024 to 2028, with rates dropping from 172.6 to 158.3. This marks annual decreases of approximately 2.1% between 2024 and 2025, and 2.3% from 2025 to 2026, 2.2% from 2026 to 2027, followed by 2.2% between 2027 and 2028. The five-year compound annual growth rate (CAGR) showcases a consistent reduction of around 2.1% annually in mortality rates.
Future trends to watch for include:
- Advancements in early cancer detection and treatment methods which may further accelerate the decline in mortality rates.
- Potential disruptions from emerging health trends or diseases that could impact neoplasm mortality.
- Public health initiatives and policies that focus on cancer prevention and awareness.
